Plain-English translation of NCT05578300 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
ENDURE-APAC is a research registry that collects information from stroke patients who receive endovascular thrombectomy—a minimally invasive procedure that removes blood clots blocking large brain arteries. By gathering data from hospitals across Asia-Pacific, researchers want to understand what factors help this procedure work best for patients outside of controlled clinical trials.
While clinical trials have shown that clot-removal procedures can be very effective, real-world hospitals may face different challenges—like longer wait times or different patient populations. This study helps doctors understand what actually works in everyday practice and how to improve stroke outcomes across the Asia-Pacific region.
You likely qualify if…
You likely don't qualify if…
If you qualify, a doctor will discuss the study with you or your family. Once you consent, researchers will collect information about your health history, current medications, and how you're doing after your clot-removal procedure. This is primarily a data collection study, so your participation mainly involves allowing doctors to gather and track your medical information over time to help improve stroke care for future patients.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
China
Hong Kong
Sponsor
Chinese University of Hong Kong
Collaborators
Linyi People's Hospital
Enrollment target
~350 participants
Started
October 2022
Primary completion
October 2032
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bonaventure Yiu Ming IP, MB ChB
Chinese University of Hong Kong
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.